Henry J. Fuchs, President, Worldwide R&D at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 31,000 shares at $90.00 ($2.8M) on 2018-06-14, disclosed to the SEC on 2018-06-18.
Seasonal sale ($2.8M) by President, Worldwide R&D — this insider has traded BMRN in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.00 | 1,875 | $169K | 6.0% |
| 2 | $90.00 | 2,000 | $180K | 6.5% |
| 3 | $90.00 | 2,669 | $240K | 8.6% |
| 4 | $90.00 | 3,775 | $340K | 12.2% |
| 5 | $90.00 | 20,681 | $1.9M | 66.7% |
| Total | $90.00 avg | 31,000 |
| $2.8M |
| 100% |
| Filing → |
| MRTX | SELL | 2022-02-14 | $1.4M | — | Filing → |
| MRTX | SELL | 2020-12-16 | $4.7M | — | Filing → |
| MRTX | SELL | 2020-08-11 | $1.6M | — | Filing → |